OCEA
Ocean Biomedical, Inc.Company Information
- Company Name
- Ocean Biomedical, Inc.
- CIK
- CIK0001869974
- Category
- <br>Emerging growth company
- Ticker: Exchange
- OCEA: None
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- OCEA
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2025-06-30
- Institutional shares owned
- 812,188
- Shares outstanding
- 91,024,268
- Ownership
- 0.89%
Earnings Market Reaction
- Filing date
- 2025-05-15
- Price on filing date
- —
- 1-month reaction
- -12.22%
- 3-month reaction
- -30.00%
Balance Sheet
Values in millions ($)| Line item | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Derivative Liabilities Noncurrent | - | - | - | - | - | - | - | 2 | - | - | - | - | ||||||
Assets | ||||||||||||||||||
| Cash Equivalents At Carrying Value | - | - | - | - | - | - | - | 1 | - | - | - | - | ||||||
| Cash | - | - | - | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 1 | ||||||
| Restricted Cash Current | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | - | - | - | - | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 2 | 0 | 2 | 1 | 1 | ||||||
| Prepaid Expense Current | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | 0 | 0 | 0 | ||||||
| Deferred Offering Costs | - | - | - | - | - | - | - | - | - | 2 | - | - | ||||||
| Due From Related Parties Current | - | - | - | - | - | - | - | - | - | 0 | - | - | ||||||
Assets Noncurrent | ||||||||||||||||||
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | 0 | 0 | 0 | 1 | 1 | 3 | - | - | - | - | - | - | ||||||
| Assets | 2 | 1 | 1 | 2 | 3 | 6 | 1 | 2 | 0 | 2 | 109 | 109 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Deferred Costs Current And Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Accounts Payable Current | 16 | 16 | 17 | 17 | 17 | 16 | 16 | 15 | 16 | 11 | 0 | 0 | ||||||
| Accrued Liabilities Current | - | - | - | - | - | 1 | 1 | 1 | 1 | 0 | 1 | 0 | ||||||
| Short Term Bank Loans And Notes Payable | - | - | - | - | - | - | - | - | 1 | - | - | - | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 27 | 34 | 34 | 31 | 30 | 30 | 31 | 30 | 24 | 13 | 2 | 1 | ||||||
| Short Term Borrowings | - | - | - | - | - | - | - | 12 | - | - | - | - | ||||||
| Loans Payable Current | 9 | 16 | 13 | 11 | 10 | 12 | 12 | - | - | 1 | - | - | ||||||
| Notes Payable Current | - | - | - | - | - | - | 0 | - | - | 2 | 1 | - | ||||||
| Derivative Liabilities Current | 0 | 1 | 4 | 2 | 2 | 1 | - | - | - | - | - | - | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Liabilities Noncurrent | - | - | - | - | - | - | 45 | 34 | 31 | - | - | - | ||||||
| Temporary Equity Value Excluding Additional Paid In Capital | - | - | - | - | - | - | - | - | - | 110 | 109 | 107 | ||||||
| Liabilities | 94 | 99 | 99 | 95 | 79 | 96 | 76 | 64 | 55 | 13 | 5 | 4 | ||||||
| Additional Paid In Capital | 121 | 108 | 108 | 108 | 107 | 105 | 104 | 103 | 99 | 71 | -2 | -1 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -92 | -98 | -98 | -93 | -76 | -91 | -75 | -62 | -55 | -11 | -10 | -10 | ||||||
| Retained Earnings Accumulated Deficit | -214 | -206 | -206 | -200 | -183 | -196 | -179 | -165 | -154 | -82 | -2 | -1 | ||||||
| Liabilities And Stockholders Equity | 2 | 1 | 1 | 2 | 3 | 6 | 1 | 2 | 0 | 2 | 109 | 109 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | - | - | - | - | - | - | - | - | 10 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 181 | - | - | ||||||
| Common Stock Shares Issued | 166 | 35 | 35 | 35 | 35 | 35 | 34 | 34 | 34 | 23 | - | - | ||||||
| Shares Outstanding | 166 | 35 | 35 | 35 | 35 | 35 | 34 | 34 | 34 | 23 | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialOcean Biomedical, Inc. (OCEA) — SEC Financial Statements & Analysis
Ocean Biomedical, Inc. (OCEA) is a pharmaceutical preparations company, incorporated in DE. Ocean Biomedical, Inc. trades on None as: OCEA. Ocean Biomedical, Inc. (OCEA)'s most recent SEC filing is a Form 10-Q for the period ended 2025-03-31, filed with the SEC on 2025-05-15. Based on that filing, Ocean Biomedical, Inc. carries a market cap of $4.92M, a P/E ratio of -0.16x, a P/B ratio of -0.05x, an enterprise value of $14.27M, and an EV/EBITDA multiple of -3.43x. On profitability, it posts a Return on Equity (ROE) of 36.53% and a Return on Assets (ROA) of -1356.85%. Per share, it reports EPS of $-0.34, diluted EPS of $-0.34, free cash flow per share of $-0.04, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 4.58% year-over-year and EPS growth of -68.58% year-over-year. On the balance sheet, it maintains a current ratio of 0.06x, a quick ratio of 0.03x, working capital of $-25.08M, a debt-to-equity ratio of -1.02x, a debt ratio of 59.41, an interest coverage ratio of -2.38x, free cash flow of $-4.05M (TTM), and net debt of $9.35M. Figures sourced from SEC EDGAR.
- Market Cap
- $4.92M
- P/E TTM
- -0.16x
- EPS TTM
- $-0.34
- P/B TTM
- -0.05x
- ROE TTM
- 36.53%
- ROA TTM
- -1356.85%
- Debt To Equity
- -1.02x
- Free Cash Flow TTM
- $-4.05M
Data as of 2025-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Ocean Biomedical, Inc. in?
Ocean Biomedical, Inc. (OCEA) operates in the Pharmaceutical Preparations industry.
What exchange does OCEA trade on?
Ocean Biomedical, Inc. (OCEA) trades on the None.
Where is Ocean Biomedical, Inc. incorporated?
Ocean Biomedical, Inc. is incorporated in DE.
When was Ocean Biomedical, Inc. (OCEA)'s most recent SEC filing?
Ocean Biomedical, Inc. (OCEA)'s most recent SEC filing is a Form 10-Q for the period ended 2025-03-31, filed with the SEC on 2025-05-15.
What is OCEA's market cap?
Ocean Biomedical, Inc. (OCEA) has a market capitalization of $4.92M as of 2025-03-31.
What is OCEA's EPS (earnings per share)?
Ocean Biomedical, Inc. (OCEA)'s trailing twelve month EPS is $-0.34 as of 2025-03-31.
What is OCEA's ROE (return on equity)?
Ocean Biomedical, Inc. (OCEA)'s trailing twelve month Return on Equity (ROE) is 36.53% as of 2025-03-31.
What is OCEA's ROA (return on assets)?
Ocean Biomedical, Inc. (OCEA)'s trailing twelve month Return on Assets (ROA) is -1356.85% as of 2025-03-31.
What is OCEA's EV/EBITDA?
Ocean Biomedical, Inc. (OCEA)'s trailing twelve month EV/EBITDA is -3.43x as of 2025-03-31.